Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes

被引:0
作者
S. Pasquini
G. Da Prato
G. Tonolo
E. Bonora
M. Trombetta
机构
[1] University of Verona,Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine
[2] SC Diabetologia Aziendale,undefined
[3] ASSL,undefined
来源
Acta Diabetologica | 2020年 / 57卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:101 / 104
页数:3
相关论文
共 17 条
[1]  
Renard E(2007)Implantable insulin pumps: a position statement about their clinical use Diabetes Metab 33 158-166
[2]  
Schaepelynck-Bélicar P(2017)A new optimized percutaneous access system for CIPII J Diabetes Sci Technol 11 814-821
[3]  
Garcia-Verdugo R(2017)Clinical pancreatic islet transplantation Nat Rev Endocrinol 13 268-277
[4]  
Erbach M(2009)Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control Diabetes Metab Res Rev 25 491-501
[5]  
Schnell O(2010)Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomised controlled trial Diabetes Care 33 1169-1172
[6]  
Shapiro AM(undefined)undefined undefined undefined undefined-undefined
[7]  
Pokrywczynska M(undefined)undefined undefined undefined undefined-undefined
[8]  
Ricordi C(undefined)undefined undefined undefined undefined-undefined
[9]  
Radermecker RP(undefined)undefined undefined undefined undefined-undefined
[10]  
Renard E(undefined)undefined undefined undefined undefined-undefined